Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories Ltd has informed the BSE that its Board of Directors will meet on 30th May 2025. The main agenda is to consider and approve the Audited Standalone Financial Results of the Company for the financial year ended 31st March 2025, prepared under Indian Accounting Standards (Ind AS). Any other business items may also be taken up with the Chair's permission. The trading window for insiders has been closed from 1st April 2025 until 48 hours after the results are publicly disclosed.
This is a routine pre-results intimation. No new financial information is disclosed here; the actual audited numbers will only be known after the 30th May 2025 board meeting. Shareholders should watch for the results announcement for any material impact on the stock.